Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Mersana Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4285917A2 | Application | Monoklonale antikörper gegen her2-epitop und verfahren zur verwendung davon | A61K2039/505; A61K2039/507; A61K38/08; A61K45/06; A61K47/6803; A61K47/6851; A61K47/6855; A61K47/6883; A61P35/00; A61P35/02; C07K16/2863; C07K16/30; C07K16/32; C07K2317/21; C07K2317/33; C07K2317/34; C07K2317/565; C07K2317/732; C07K2317/76; C07K2317/77; C07K2317/92 | December 06, 2023 |
| EP3641826B1 | Grant | Verfahren zur herstellung von wirkstofftragenden polymergerüsten und protein-polymer-wirkstoff-konjugaten | A61K38/08; A61K47/59; A61K47/64; A61K47/6803; A61K47/6835; A61K47/6849; A61K47/6851; A61K47/6883 | December 06, 2023 |
| WO2023225559A1 | Application | B7-h4-targeted antibody-drug conjugates for the treatment of cancer | A61K2039/505; A61K2039/545; A61K2039/55; A61K47/6849; A61K47/6851; A61P35/00; C07K16/2827; C07K2317/56; C07K2317/565; C07K2317/73; A61K47/68031 | November 23, 2023 |
| US20230355787A1 | Application | Compositions and methods for predicting response to napi2b-targeted therapy | A61K2039/505; A61K47/6803; A61K47/6849; A61K47/6857; A61K47/6869; A61K47/6889; A61K49/0004; A61P35/00; C07K16/28; C07K16/30; G01N33/574; G01N33/57423; G01N33/57449; G01N33/57492 | November 09, 2023 |
| EP4271713A1 | Application | Gegen b7h4 gerichtete antikörper-wirkstoff-konjugate und verfahren zur verwendung davon | A61K47/6883; A61K47/6807; A61K47/6851; A61K47/6849; A61K47/6857; A61K47/6869; A61K47/6803; C07K16/3069; C07K2317/21; A61K2039/505; C07K2317/24; C07K16/32; C07K16/2827; C07K2317/565; C07K2317/73; C07K2317/92; C07K2317/94; A61P35/00; C07K16/3023; A61K47/68031 | November 08, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer